| Euro Manganese Inc (EMN) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$24 |
Interim Financial Statements for Quarter ended 12/31/25
|
18 Feb 2026 8:16AM |
$0.195 |
$0.165 |
fallen by
15.38%
|
|
EMN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss for the quarter was $3.633 million.
- Revenues increased to $1.147 million.
- Significant expenses for the Chvaletice Project evaluation at $1.497 million.
- Total assets were $33.544 million, with liabilities at $34.220 million.
- Development focus on the Chvaletice Manganese Project and potential Canadian opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$4,389 |
Telix Submits EU MAA for TLX101-Px Brain Cancer Imaging
|
18 Feb 2026 8:16AM |
$8.840 |
$12.950 |
risen by
46.49%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix submits European MAA for TLX101-Px.
- TLX101-Px aims to improve glioma imaging in Europe.
- Submission involves collaboration with European regulatory agencies.
- Regulatory alignment with U.S. FDA package expedites EU filing.
- TLX101-Px to potentially aid Telix's glioblastoma therapy assessments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$11,272 |
Appendix 3Y - Richard Freudenstein
|
18 Feb 2026 8:16AM |
$199.810 |
$172.360 |
fallen by
13.74%
|
|
| Healius Limited (HLS) ORDINARY FULLY PAID |
Health Care |
$378 |
Healius announces 1H 2026 results
|
18 Feb 2026 8:16AM |
$0.815 |
$0.520 |
fallen by
36.20%
|
|
HLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue up 3.8% to $688.1 million.
- Underlying EBITDA up 13.1% to $122.2 million.
- Underlying EBIT $7.9 million from a loss in 1H25.
- Pathology revenue increased by 3.5%.
- Agilex revenue grew by 16.0%.
- Cost management limited increase to 1.9%.
- Implementation of AI and digital solutions.
- Contract with Australian Department of Defence worth $60 million.
- High single-digit EBIT margins expected by June 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Endeavour Group Limited (EDV) ORDINARY FULLY PAID |
Consumer Staple |
$5,746 |
Endeavour Group Board Update
|
18 Feb 2026 8:16AM |
$3.840 |
$3.200 |
fallen by
16.67%
|
|
| Healius Limited (HLS) ORDINARY FULLY PAID |
Health Care |
$378 |
Half Year 2026 Results Presentation
|
18 Feb 2026 8:16AM |
$0.815 |
$0.520 |
fallen by
36.20%
|
|
HLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Healius Limited reported a group revenue growth of $25.5 million, an increase of 3.8%, to $688.1 million for the first half of 2026.
- Pathology revenue rose by $22.5 million, or 3.5%, reaching $666.3 million.
- The group's underlying EBITDA increased by $14.2 million, marking a 13.1% rise to $122.2 million.
- Pathology's EBITDA went up by $12.3 million (11.7%) to $117.4 million, while Agilex Biolabs' EBITDA increased by $1.9 million (65.5%) to $4.8 million.
- A significant technology investment was made, including the launch of AI co-workers and the Medway Collectors and Results Portals.
- The company achieved a net cash position of $11.6 million by the end of December 2025.
- Healius is focused on cost reduction strategies, resulting in annualized support cost savings and a digital transformation program.
- Labour optimization and cost management have been key drivers for the operational efficiency gains reported.
- The strategic pivot towards large molecule work by Agilex Biolabs has contributed positively to margin expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Healius Limited (HLS) ORDINARY FULLY PAID |
Health Care |
$378 |
Half Yearly Report and Accounts
|
18 Feb 2026 8:16AM |
$0.815 |
$0.520 |
fallen by
36.20%
|
|
HLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Net comprehensive loss for the period was $30.8 million.
- Reported net loss after tax was $30.4 million.
- Revenue increased by 3.8% to $688.1 million.
- Underlying EBITDA increased by 13.1% to $122.2 million.
- Financial pressures in the pathology sector due to non-indexation of Medicare Benefits Schedule.
- Rising employment costs following Fair Work Commission decision.
- Continued demand for pathology services driven by aging population and genomic diagnostics.
- Total assets amounted to $1,773.5 million.
- Total liabilities were $1,216.4 million.
- Net assets were reported at $557.1 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$4 |
5EA - Form 10-Q - Quarterly Results 31 December 2025
|
18 Feb 2026 8:15AM |
$0.325 |
$0.215 |
fallen by
33.85%
|
|
5EA - Price-sensitive ASX Announcement
Full Release
Key Points
- 5E Advanced Materials is focused on borates and advanced boron materials.
- Quarterly report for period ending December 31, 2025.
- Executed a reverse stock split in February 2025.
- Reported ongoing financial challenges and reliance on financing.
- Substantial doubt about the company's ability to continue without additional funding.
- Continues development of the 5E Boron Americas Complex.
- Emphasizes sustainable and secure supply of critical materials.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| St Barbara Limited (SBM) ORDINARY FULLY PAID |
Materials |
$768 |
Change in substantial holding
|
18 Feb 2026 8:15AM |
$0.735 |
$0.635 |
fallen by
13.61%
|
|
| Euro Manganese Inc (EMN) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$24 |
Euro Manganese Announces Appointment of Director
|
18 Feb 2026 8:15AM |
$0.195 |
$0.165 |
fallen by
15.38%
|
|
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$5 |
Percheron Therapeutics Limited - Corporate Presentation
|
18 Feb 2026 8:15AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$26,819 |
Change in substantial holding
|
18 Feb 2026 8:15AM |
$83.010 |
$101.740 |
risen by
22.56%
|
|
| Australian Finance Group Ltd (AFG) ORDINARY FULLY PAID |
Financials |
$495 |
AFG FY26 Half Year Results Investor Presentation
|
18 Feb 2026 8:15AM |
$2.040 |
$1.820 |
fallen by
10.78%
|
|
AFG - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit for H1 FY26 up by 43% to $24 million.
- Subscription income increased by 11%, now 20% of distribution gross profit.
- Eight consecutive years of growth in broker services income.
- Operating expenses increased by $0.7 million, primarily due to technology enhancements and broker engagement.
- AFG Securities reported a 99% increase in lodgement growth.
- Transition to higher margin AFG Securities products as white label volumes reduce.
- Net cash from operating activities rose by 50% to $20 million.
- Underlying return on equity increased to 21%.
- Declared interim dividend of 4.7 cents per share for FY26.
- Focus on leveraging network scale and investing in high-return segments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Finance Group Ltd (AFG) ORDINARY FULLY PAID |
Financials |
$495 |
AFG FY26 Half Year Results Market Release
|
18 Feb 2026 8:14AM |
$2.040 |
$1.820 |
fallen by
10.78%
|
|
AFG - Price-sensitive ASX Announcement
Full Release
Key Points
- Record half-year result for AFG with NPAT up 46% to $22.4 million.
- Underlying gross profit increased 16% to $79 million.
- EBITDA surged 43% to $35.6 million.
- AFG brokers now write 1 in 9 residential home loans nationally.
- AFG Securities achieved a record loan book of $6.3 billion.
- BrokerEngine Plus adoption increased by 23%, with subscription income up 11%.
- Reduced cost-to-income ratio to 56%.
- Favorable funding terms reduced sensitivity to cash rate changes.
- Strategic focus on broker network expansion and technology enhancements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Finance Group Ltd (AFG) ORDINARY FULLY PAID |
Financials |
$495 |
Dividend/Distribution - AFG
|
18 Feb 2026 8:14AM |
$2.040 |
$1.820 |
fallen by
10.78%
|
|
| Australian Finance Group Ltd (AFG) ORDINARY FULLY PAID |
Financials |
$495 |
AFG Appendix 4D and FY26 Half Year Financial Report
|
18 Feb 2026 8:14AM |
$2.040 |
$1.820 |
fallen by
10.78%
|
|
AFG - Price-sensitive ASX Announcement
Full Release
Key Points
- The report covers the half-year ended 31 December 2025.
- Revenue from ordinary activities increased by 14.3% to $715 million compared to the previous corresponding period.
- Net profit after tax (NPAT) for the period was $22.4 million, which is a 46.4% increase from the prior period.
- The underlying NPAT plus amortisation from continuing operations increased by 42.6% to $24.1 million.
- An interim dividend of 4.7 cents per share, fully franked, was declared.
- The company operates in three segments: Distribution, Manufacturing, and Central.
- The Distribution segment is the largest, contributing 72% of EBITDA, primarily through aggregation services.
- The Manufacturing segment includes AFG Securities mortgages and contributes 28% of EBITDA.
- Assets totaled $7.924 billion, and liabilities totaled $7.693 billion, resulting in net assets of $231.4 million as of 31 December 2025.
- The auditor's review concluded that the financial report complies with the Corporations Act 2001 and presents a true and fair view of the company’s financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Novo Resources Corp. (NVO) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$29 |
Corporate Presentation February 2026
|
18 Feb 2026 8:14AM |
$0.125 |
$0.081 |
fallen by
35.20%
|
|
| Bayan Mining and Minerals Limited (BMM) ORDINARY FULLY PAID |
Materials |
$11 |
Plan of Operations/Strategic Land Expansion at Bayan Springs
|
18 Feb 2026 8:14AM |
$0.086 |
$0.084 |
fallen by
2.33%
|
|
BMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Plan of Operations submitted for Bayan Springs South Project
- Strategic land expansion with 13 new lode claims
- Focus on high-priority drill targets identified in collaboration with experts
- Potential for Carlin-type mineralization
- Project located near major gold mining operations
- Anticipated approval for drilling within 45 days
- Collaborative efforts with experienced geologists
- Significant geological indicators warranting drill testing
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Biome Australia Limited (BIO) ORDINARY FULLY PAID |
Consumer Staple |
$78 |
Biome Half Year Results and Webinar
|
18 Feb 2026 8:14AM |
$0.420 |
$0.340 |
fallen by
19.05%
|
|
| Premier1 Lithium Limited (PLC) ORDINARY FULLY PAID |
Materials |
$9 |
Commencement of Drilling at Mt Kersey Gold Prospect
|
18 Feb 2026 8:14AM |
$0.011 |
$0.010 |
fallen by
9.09%
|
|
PLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Premier1 commenced a 3,700m RC drilling program at Mt Kersey Gold Prospect.
- 100% acquisition of the Yalgoo Gold Project enhances exploration potential.
- Drilling targets a 5 km² mineralized zone with hydrothermal system.
- Non-dilutive funding includes $180,000 from WA's Exploration Incentive Scheme.
- Drilling supported by $176,000 credit from the drilling contractor.
- Program expected to complete in two weeks with assay results to follow.
- Exploration potential in Yalgoo district highlighted by Premier1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Omega Oil & Gas Limited (OMA) ORDINARY FULLY PAID |
Energy |
$351 |
Investor Presentation - North American Prospect Expo
|
18 Feb 2026 8:13AM |
$0.515 |
$0.750 |
risen by
45.63%
|
|
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$9 |
Central Yilgarn Drilling Supports Gold Mineralisation Model
|
18 Feb 2026 8:13AM |
$0.084 |
$0.061 |
fallen by
27.38%
|
|
CTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 1 RC drilling completed at Viper Prospects, Central Yilgarn Project.
- Gold mineralisation associated with mafic and BIF lithology.
- Significant gold intersections detected in several drill holes.
- Drilling supports potential for a coherent gold system within Central Yilgarn tenure.
- Catalina is integrating results into ongoing targeting with additional assays pending.
- This forms part of Catalina's broader Central Yilgarn drilling campaign.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metals Australia Ltd (MLS) ORDINARY FULLY PAID |
Materials |
$17 |
High Grade Assays Verify the Emerging Manindi VTM Project
|
18 Feb 2026 8:13AM |
$0.021 |
$0.023 |
risen by
9.52%
|
|
MLS - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade Vanadium-Titanium-Magnetite (VTM) confirmed at Manindi West.
- Discovery Zone extended over 1,200m with high-grade intervals.
- Significant assay results include high V2O5, TiO2, and Fe concentrations.
- Metallurgical testing shows potential for high-purity TiO2 production.
- The true width of mineralization ranges from 75 to 95 meters.
- Vertical depth of mineralization extends up to 260 meters below the surface.
- Focus on producing =97% TiO2 grade product.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Polynovo Limited (PNV) ORDINARY FULLY PAID |
Health Care |
$646 |
Change in substantial holding
|
18 Feb 2026 8:13AM |
$0.955 |
$0.935 |
fallen by
2.09%
|
|
| Brazilian Rare Earths Limited (BRE) ORDINARY FULLY PAID |
Materials |
$1,136 |
Monte Alto Expands with New Ultra-High Grade Discoveries
|
18 Feb 2026 8:13AM |
$3.950 |
$4.120 |
risen by
4.30%
|
|
BRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Monte Alto project shows ultra-high grade rare earth elements (REE) mineralisation.
- Recent drilling results confirm the presence of high-grade REE in the central zone.
- The project has potential for further expansion and contains world-class mineralisation.
- Significant intercepts of neodymium and praseodymium have been reported.
- Brazilian Rare Earths Limited (BRE) leads the exploration efforts.
- Monte Alto's central zone demonstrates exceptional grade and scale.
- The report highlights cumulative mineralised thickness reaching up to 43 meters.
- Key elements found include neodymium, dysprosium, and tantalum.
- Exploration results are supported by ongoing drilling campaigns.
- The project strengthens BRE's portfolio with its rich REE deposits.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
